Gaziano T, Reddy KS, Paccaud F, Horton S, Chaturvedi V. Cardiovascular Disease. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Dis Control Priorities Dev Ctries [Internet]. 2nd ed. Washington (DC): World Bank; 2006 [cited 2019 Nov 5]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11767/.

Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.

PubMed  PubMed Central  Article  Google Scholar 

Bergheanu SC, Bodde MC, Jukema JW. Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatment. Neth Heart J Mon J Neth Soc Cardiol Neth Heart Found [Internet]. Neth Heart J.; 2017 [cited 2021 May 24];25. Available from: https://pubmed.ncbi.nlm.nih.gov/28194698/.

Manjunath CN, Rawal JR, Irani PM, Madhu K. Atherogenic dyslipidemia. Indian J. Endocrinol Metab. 2013;17:969–76.

CAS  Google Scholar 

Kazemi T, Hajihosseini M, Moossavi M, Hemmati M, Ziaee M. Cardiovascular risk factors and atherogenic indices in an Iranian population: Birjand East of Iran. Clin Med Insights Cardiol. 2018;12:1–6.

Article  Google Scholar 

Sarafian MH, Ding NS, Holmes E, Hart A. Chapter 28—effect on the host metabolism. In: Floch MH, Ringel Y, Allan Walker W, editors. Microbiota gastrointestinal pathophysiology [Internet]. Boston: Academic Press; 2017 [cited 2021 May 24]. p. 249–53. Available from: https://www.sciencedirect.com/science/article/pii/B9780128040249000288.

Tang WHW, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res Am Heart Assoc. 2017;120:1183–96.

CAS  Google Scholar 

Chen Z-Y, Ma KY, Liang Y, Peng C, Zuo Y. Role and classification of cholesterol-lowering functional foods. J Funct Foods. 2011;3:61–9.

Article  CAS  Google Scholar 

Poli A, Barbagallo CM, Cicero AFG, Corsini A, Manzato E, Trimarco B, et al. Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper. Pharmacol Res. 2018;134:51–60.

CAS  PubMed  Article  Google Scholar 

Ward N, Sahebkar A, Banach M, Watts G. Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents. Curr Opin Lipidol. 2017;28:495–501.

CAS  PubMed  Article  Google Scholar 

Hao W, Zhu H, Chen J, Kwek E, He Z, Liu J, et al. Wild melon seed oil reduces plasma cholesterol and modulates gut microbiota in hypercholesterolemic hamsters. J Agric Food Chem. 2020;68:2071–81.

CAS  PubMed  Article  Google Scholar 

He Z, Hao W, Kwek E, Lei L, Liu J, Zhu H, et al. Fish oil is more potent than flaxseed oil in modulating gut microbiota and reducing trimethylamine-N-oxide-exacerbated atherogenesis. J Agric Food Chem. 2019;67:13635–47.

CAS  PubMed  Article  Google Scholar 

Huyben D, Roehe BK, Bekaert M, Ruyter B, Glencross B. Dietary Lipid:Protein Ratio and n-3 Long-Chain Polyunsaturated Fatty Acids Alters the Gut Microbiome of Atlantic Salmon Under Hypoxic and Normoxic Conditions. Front Microbiol [Internet]. Frontiers; 2020 [cited 2021 May 11];11. https://doi.org/10.3389/fmicb.2020.589898/full

Özcan M, Hacıseferoğulları H, Marakoğlu T, Arslan D. Hawthorn (Crataegus spp.) fruit: some physical and chemical properties. J Food Eng. 2005;69:409–13.

Article  Google Scholar 

Bahorun T, Gressier B, Trotin F, Brunet C, Dine T, Luyckx M, et al. Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations. Arzneimittelforschung. 1996;46:1086–9.

CAS  PubMed  Google Scholar 

Kéry A, Verzárné Petri G, Incze I. Comparative study of flavonoids form Crataegus oxyacantha L. and Crataegus monogyna Jacq. Acta Pharm Hung. 1977;47:11–23.

PubMed  Google Scholar 

Chang Q, Zuo Z, Harrison F, Chow MSS. Hawthorn. J Clin Pharmacol. 2002;42:605–12.

PubMed  Article  Google Scholar 

Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2002;59:417–22.

Article  Google Scholar 

Shanthi S, Parasakthy K, Deepalakshmi PD, Devaraj SN. Hypolipidemic activity of tincture of Crataegus in rats. Indian J Biochem Biophys. 1994;31:143–6.

CAS  PubMed  Google Scholar 

Shanthi R, Parasakthy K, Deepalakshmi PD, Niranjali DS. Protective effect of tincture of Crataegus on oxidative stress in experimental atherosclerosis in rats. J Clin Biochem Nutr. 1996;20:211–23.

CAS  Article  Google Scholar 

Chen JD, Wu YZ, Tao ZL, Chen ZM, Liu XP. Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Rev Nutr Diet. 1995;77:147–54.

CAS  PubMed  Article  Google Scholar 

Zhu H, Chen J, He Z, Hao W, Liu J, Kwek E, et al. Soybean germ oil reduces blood cholesterol by inhibiting cholesterol absorption and enhancing bile acid excretion. Food Funct. 2019;10:1836–45.

CAS  PubMed  Article  Google Scholar 

Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997;127:838S-841S.

CAS  PubMed  Article  Google Scholar 

Wilson TA, Romano C, Liang J, Nicolosi RJ. The hypocholesterolemic and antiatherogenic effects of chiolazol H, a chemically functionalized insoluble fiber with bile acid sequestrand properties in hamsters. Metabolism. 1998;47:959–64.

CAS  PubMed  Article  Google Scholar 

Kwek E, Zhu H, Ding H, He Z, Hao W, Liu J, et al. Peony seed oil decreases plasma cholesterol and favorably modulates gut microbiota in hypercholesterolemic hamsters. Eur J Nutr [Internet]. 2022. https://doi.org/10.1007/s00394-021-02785-9

Si W, Liang Y, Ma KY, Chung HY, Chen Z-Y. Antioxidant activity of capsaicinoid in canola oil. J Agric Food Chem. 2012;60:6230–4.

CAS  PubMed  Article  Google Scholar 

Lei L, Chen J, Liu Y, Wang L, Zhao G, Chen Z-Y. Dietary wheat bran oil is equally as effective as rice bran oil in reducing plasma cholesterol. J Agric Food Chem. 2018;66:2765–74.

CAS  PubMed  Article  Google Scholar 

He Z, Kwek E, Hao W, Zhu H, Liu J, Ma KY, et al. Hawthorn fruit extract reduced trimethylamine-N-oxide (TMAO)-exacerbated atherogenesis in mice via anti-inflammation and anti-oxidation. Nutr Metab. 2021;18:6.

CAS  Article  Google Scholar 

Liu J, Hao W, He Z, Kwek E, Zhao Y, Zhu H, et al. Beneficial effects of tea water extracts on the body weight and gut microbiota in C57BL/6J mice fed with a high-fat diet. Food Funct. 2019;10:2847–60.

CAS  PubMed  Article  Google Scholar 

Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet. 2009;10:109–21.

CAS  PubMed  Article  Google Scholar 

Kumari A. Chapter 7—cholesterol synthesis. In: Kumari A, editor. Sweet Biochem [Internet]. Academic Press; 2018 [cited 2021 May 17]. p. 27–31. Available from: https://www.sciencedirect.com/science/article/pii/B9780128144534000078.

DeBose-Boyd RA. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 2008;18:609–21.

CAS  PubMed  Article  Google Scholar 

Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125–31.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86:839–48.

PubMed  Article  CAS  Google Scholar 

Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome. 2020;8:36.

PubMed  PubMed Central  Article  Google Scholar 

Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci. 2014;111:7421.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ryan PM, Stanton C, Caplice NM. Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions. Diabetol Metab Syndr. 2017;9:102.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res Am Heart Assoc. 2020;127:553–70.

CAS  Google Scholar 

Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021;13:1897212.

PubMed Central  Article  CAS  Google Scholar 

den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325–40.

Article  CAS  Google Scholar 

Zhang M, Feng R, Yang M, Qian C, Wang Z, Liu W, et al. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats. BMJ Open Diabetes Res Care. 2019;7:e000717.

PubMed  PubMed Central  Article  Google Scholar 

Malaguarnera M, Giugno I, Ruello P, Rizzo M, Motta M, Mazzoleni G. Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias. Br J Clin Pharmacol. 1999;48:605–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Walter-Sack IE, Wolfram G, Zöllner N. Effects of acarbose on serum lipoproteins in healthy individuals during prolonged administration of a fiber-free formula diet. Ann Nutr Metab. 1989;33:100–7.

CAS  PubMed  Article  Google Scholar 

Mao G, Li S, Orfila C, Shen X, Zhou S, Linhardt RJ, et al. Depolymerized RG-I-enriched pectin from citrus segment membranes modulates gut microbiota, increases SCFA production, and promotes the growth of Bifidobacterium spp., Lactobacillus spp. and Faecalibaculum spp. Food Funct. 2019;10:7828–43.

CAS  PubMed  Article  Google Scholar 

Zagato E, Pozzi C, Bertocchi A, Schioppa T, Saccheri F, Guglietta S, et al. Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth. Nat Microbiol. 2020;5:511–24.

CAS